Aurora Cannabis Supporting Medical Cannabis Educational Initiative In Germany
Monday, 10 May 2021, 18:44:24
Canadian cannabis giant Aurora Cannabis, Inc. (NYSE: ACB ) via its Berlin-based subsidiary Aurora Europe is supporting a medical cannabis-related educational initiative in Germany with €38,000 ($46,198), reported Hemp Today . Students at Humboldt University of Berlin can now expand their study of medical cannabis by taking part in an interdisciplinary cannabis research class, which is also financially backed by the German Ministry of Education, Research and Science. Created by Humboldt University in 2013, the cannabis science course was conceived with the idea of … Full story available on Benzinga.com
Is Aurora Cannabis a Buy Before This Week's Earnings Report?
Monday, 10 May 2021, 18:30:43
The CEO of cannabis giant Aurora explains why he's laser focused on plant genetics and predicts a ‘Monsanto' of cannabis will emerge
Monday, 3 May 2021, 14:30:00
Summary List Placement Aurora Cannabis CEO Miguel Martin thinks the cannabis industry , and those who pay close attention to it, aren't talking enough about the value of plant genetics. “There's going to be a cannabis company that looks more like Monsanto,” Martin said in an interview with Insider, referring to the agricultural and chemical company best known for genetically modified crops. Aurora is the second-biggest cannabis company by market cap in the world. By that, he means companies that want to dominate the emerging industry will need to create cannabis strains with specific genetic profiles that give users the desired taste, smell, and psychoactive effects — and be sure that the product can be replicated consistently across different markets. These types of products can command higher prices on the dispensary shelf, and offer producers higher margins as well, analysts say. Monsanto was the subject of a lot of criticism for its role in the proliferation of genetically modified crops — some of it fair, some not so much.
— Business Insider
Canadian Cannabis: Why This Penny Stock Is ‘Arguably The Best Value'
Friday, 30 April 2021, 18:25:22
Top Canadian cannabis stocks, including Tilray Inc (NASDAQ: TLRY ), Aphria Inc (NASDAQ: APHA ) and Aurora Cannabis Inc (NYSE: ACB ), have been red-hot in the last six months. On Friday, Cantor Fitzgerald analyst Pablo Zuanic said Canadian cannabis penny stock Auxly Cannabis Group Inc (OTCQX: CBWTF ) is “arguably the best value” among Canadian legal producers. The Auxly Analyst: Zuanic has an Outperform rating and 69-cent price target for Auxly, representing more than 100% upside from its current level of around 30 cents. Related Link: 6 Long-Term Themes Cannabis Investors Should Watch The Auxly Thesis: Auxly is now the fifth-largest Canadian … Full story available on Benzinga.com
BofA On Cannabis Stocks: Bullish On Tilray, Canopy Growth, Bearish On Cronos
Wednesday, 28 April 2021, 18:16:53
Valuation multiples for cannabis stocks are likely to expand over the next year as the U.S. government reaches milestones on the path to federal cannabis legalization, according to BofA Securities. The Cannabis Analyst: Heather Balsky reinstated coverage of four cannabis stocks in separate notes: Tilray Inc (NASDAQ: TLRY ) with a Buy rating and $23 price target. Canopy Growth Corp (NASDAQ: CGC ) with a Buy and a $36 price target. Aurora Cannabis Inc (NYSE: ACB ) with a Neutral rating and $9.60 price target. Cronos Group Inc (NASDAQ: CRON ) with an Underperform rating and $7.50 price target. The … Full story available on Benzinga.com
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.